A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occupancy (D2RO) in rat striatum following administration of olanzapine, an atypical antipsychotic drug.A population approach was utilized to quantify both the pharmacokinetics and pharmacodynamics of olanzapine in rats using the exposure (plasma and brain concentration) and D2RO profile obtained experimentally at various doses (0.01-40 mg/kg) administered by different routes. A two-compartment pharmacokinetic model was used to describe the plasma pharmacokinetic profile. A hybrid physiology- and mechanism-based model was developed to characterize the D-2 receptor binding in the striatum and was fitted sequentially to the data. The parameters wer...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
Objective: Two structurally different mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) models...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
Objectives: A hybrid physiology-based pharmacokinetic and pharmacodynamic model (PBPKPD) was used to...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
A mechanism-based PK-PD model was developed to predict the time course of dopamine D-2 receptor occu...
Objective: Two structurally different mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) models...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
Objectives: A hybrid physiology-based pharmacokinetic and pharmacodynamic model (PBPKPD) was used to...
OBJECTIVES: To assess the ability of a previously developed hybrid physiology-based pharmacokinetic-...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...
A pharmacokinetic-pharmacodynamic (PK-PD) model was developed to describe the time course of brain c...